UTI Asset Management Company Ltd (UTIAMC) Q1 FY27 Results Analysis: Cost-to-Income Improves 344 bps, Revenue Growth Elusive

CompoundingAI Research Updated July 23, 2026 2 min read
Neutral

UTI Asset Management Company Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 378.74 Cr (-0.15% YoY) and PAT growth of +24.07% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 22, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 378.74 Cr (-0.15% YoY)
PAT (Q1)Rs. 293.86 Cr (+24.07% YoY)
EBITDA margin65.30%
EPS (Q1)Rs. 22.86 (+23.57% YoY)
Market capRs. 11,614.86 Cr
CMPRs. 904.05

Quarter Snapshot

UTIAMC delivered a cost-heavy quarter with employee expenses below guidance and a 344 bps improvement in cost-to-income. However, core income was flat and market share continued to erode. PAT growth was inflated by fair value gains, making normalized earnings the better metric. The VRS cost savings are visible but revenue growth remains elusive.

Key Investment Insights

Key Positives

  • Consolidated employee cost of Rs.121.63 Cr was below management's guidance of ~Rs.125 Cr, confirming VRS cost savings.
  • Cost-to-Income ratio improved 344 bps YoY to 37.13%, reflecting strong cost discipline.
  • Normalized PAT (excluding fair value gains) grew 22.82% YoY to Rs.144.40 Cr, driven by cost savings.
  • Total expenses decreased 2.38% YoY even as total income grew 6.68%.

Risk Factors

  • Sale of services (core income) declined 0.15% YoY to Rs.378.74 Cr, indicating flat revenue growth.
  • International revenue dropped 24.96% YoY to Rs.25.41 Cr due to currency devaluation and AUM decline.
  • Reported PAT was inflated by Rs.187.13 Cr of fair-value gains; normalized PAT is lower at Rs.144.40 Cr.
  • Domestic revenue growth of 2.29% YoY lags industry pace, continuing market share erosion.
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now